As of 2025-02-12, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (15,029.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.31 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -4890825.1%.
The range of the Relative Valuation is (13,648.47) - (18,352.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 30.0x | 16.6x |
| Forward P/E multiples | 22.3x - 33.6x | 32.6x |
| Fair Price | (13,648.47) - (18,352.73) | (15,029.20) |
| Upside | -4441514.6% - -5972351.3% | -4890825.1% |
| Date | P/E |
| 2025-02-06 | -0.00 |
| 2025-02-05 | -0.00 |
| 2025-02-04 | -0.00 |
| 2025-02-03 | -0.00 |
| 2025-01-31 | -0.00 |
| 2025-01-30 | -0.00 |
| 2025-01-29 | -0.00 |
| 2025-01-28 | -0.00 |
| 2025-01-27 | -0.00 |
| 2025-01-24 | -0.00 |
| 2025-01-23 | -0.00 |
| 2025-01-22 | -0.00 |
| 2025-01-21 | -0.00 |
| 2025-01-17 | -0.00 |
| 2025-01-16 | -0.00 |
| 2025-01-15 | -0.00 |
| 2025-01-14 | -0.00 |
| 2025-01-13 | -0.00 |
| 2025-01-10 | -0.00 |
| 2025-01-08 | -0.00 |
| 2025-01-07 | -0.00 |
| 2025-01-06 | -0.00 |
| 2025-01-03 | -0.00 |
| 2025-01-02 | -0.00 |
| 2024-12-31 | -0.00 |
| 2024-12-30 | -0.00 |
| 2024-12-27 | -0.00 |
| 2024-12-26 | -0.00 |
| 2024-12-24 | -0.00 |
| 2024-12-23 | -0.00 |
| 2024-12-20 | -0.00 |
| 2024-12-19 | -0.00 |
| 2024-12-18 | -0.00 |
| 2024-12-17 | -0.00 |
| 2024-12-16 | -0.00 |
| 2024-12-13 | -0.00 |
| 2024-12-12 | -0.00 |
| 2024-12-11 | -0.00 |
| 2024-12-10 | -0.00 |
| 2024-12-09 | -0.00 |
| 2024-12-06 | -0.00 |
| 2024-12-05 | -0.00 |
| 2024-12-04 | -0.00 |
| 2024-12-03 | -0.00 |
| 2024-12-02 | -0.00 |
| 2024-11-29 | -0.00 |
| 2024-11-27 | -0.00 |
| 2024-11-26 | -0.00 |
| 2024-11-25 | -0.00 |
| 2024-11-22 | -0.00 |